Cargando…
Prostate cancer with neuroendocrine differentiation – case report
Rationale: About 95% of prostate cancers are adenocarcinoamas. Depending on the detection method used, neuroendocrine cells are found in 10% to 100% of prostate cancer specimens. Objective: A 64-year-old patient was diagnosed in 2006 with adenocarcinoma of the prostate, PSA 4.1 ng/ml, Gleason 6, T3b...
Autores principales: | Glück, G, Mihai, M, Stoica, R, Andrei, R, Sinescu, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307067/ https://www.ncbi.nlm.nih.gov/pubmed/22574096 |
Ejemplares similares
-
Comparative study of conventional urothelial carcinoma, squamous differentiation carcinoma and pure squamous carcinoma in patients with invasive bladder tumors
por: Gluck, G, et al.
Publicado: (2014) -
Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
por: Hingorani, Rittu, et al.
Publicado: (2014) -
Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer
por: Mori, Hiroshi, et al.
Publicado: (2018) -
Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
por: Minagawa, Hideyuki, et al.
Publicado: (2021) -
Finger enchondroma treated with bone substituents – a case presentation
por: Raducu, L, et al.
Publicado: (2014)